Pirl

Americas Opioid Epidemic: The FDA has Stated the Benefits No Longer Outweigh the Public Health Risk

samantha severyn

Statistics from the Center for Disease Control (CDC) in 2014 stated that over 90 Americans die from a prescription opioid overdose daily, that’s nearly 33,000 people a year![1] And over 1,000 individuals were treated in the hospital for prescription opioid-related problems on a daily basis![2] In addition, the CDC stated that in 2014 the number of known Americans dependent on their medically prescribed opioids was 2 Million! BY 2017 THOSE NUMBERS HAVE DOUBLED![3]  

According to the Department of Health & Human Services, an average of 650,000 Medically Prescribed Opioids are dispensed on a daily basis.[4] That’s about 400 Million medically prescribed Mass-produced opioids being handed out by professional doctors yearly in America, with the numbers steadily rising.

After years of the CDC trying to address the issue as if it were a consumer problem or characteristical flaw they finally have started to address the real problem…BIG PHARMA! In March 2016, the CDC released their updated Guidelines for Doctors to use to prescribe opioids for chronic pain and guidelines on providing recommendations for the prescribing of opioid pain medication for patients 18 and older in primary care settings.

Now in 2017, in a revolutionary step to clean up the medical fields push of opioids on the population, the U.S. Food and Drug Administration has formally requested that Opana ER is taken off the market!

Endo Pharmaceuticals, makers of the opioid Opana ER, are being forced by the FDA to withdraw the drug or they will initiate the formal process to begin the removal of the prescription drug by withdrawing their approval of it.

The FDA’s decision followed a review from an advisory committee whose members voted 18-8 that the benefits of Opana ER no longer outweighed the risks. FDA Commissioner Scott Gottleib said in a press release that the nation is facing a public health crisis with regard to prescribed opioids and agencies must take necessary steps to reduce it. Gottleib stated, “We will continue to take regulatory steps when we see situations where an opioid product’s risks outweigh its benefits.” Dr. Janet Woodcock, Director of the FDA’s Center for Drug Evaluation and Research, added, "When we determined that the product had dangerous unintended consequences, we made a decision to request its withdrawal from the market."

Now it is up to Endo to willingly pull the drug before the FDA formally withdraws their approval of it.

Remember: Opana ER is just a small fish in the sea of mass produced opioids… don’t be a victim of Big Pharma’s money-making scams. Search an Alternative route for the relief you need in life before blindly accepting their offer.

Check out Pirls report on the Mass Opioid Addiction Drug Manufacturers Lawsuit, several NewYork Counties have already started filing suits against Big Pharma for deceiving the public, false advertisement, and fraud. Additionally, similar lawsuits have been filed in Mississippi, Illinois, Ohio, and two counties in California.

 

If you or a loved one struggles with opioid addiction, please contact us at Info@MyPirl.com. We are here to help you! Or call an Opioid and Opiate Addiction Recovery Hotline at 888-319-2606.

 

*****A VITAL NOTE FROM THE PIRL TEAM: As we report on any medical product/medication case - NEVER STOP OR ALTER A MEDICAL PROGRAM OR COURSE OF MEDICATION WITHOUT CONSULTING YOUR(S) OR A PHYSICIAN.*****

 

 

 

[1] https://www.cdc.gov/drugoverdose/data/statedeaths.html

[2] https://www.cdc.gov/drugoverdose/data/overdose.html

[3] https://www.hhs.gov/sites/default/files/Factsheet-opioids-061516.pdf

[4] https://www.hhs.gov/sites/default/files/Factsheet-opioids-061516.pdf